Your browser doesn't support javascript.
loading
Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye.
Cicin, Irfan; Karadurmus, Nuri; Bilici, Ahmet; Bahsi, Taha; Sendur, Mehmet Ali; Demirci, Umut; Goksu, Sema Sezgin; Er, Ozlem; Bisgin, Atil; Ozturk Saglam, Ozge Fulya; Aver, Birkan; Kilickap, Saadettin.
Afiliación
  • Cicin I; Istinye University, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Türkiye.
  • Karadurmus N; Gulhane Research & Training Hospital, Department of Internal Medicine, Division of Medical Oncology, Ankara, Türkiye.
  • Bilici A; Medipol University, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Türkiye.
  • Bahsi T; Ankara Etlik City Hospital, Department of Medical Genetics, Ankara, Türkiye.
  • Sendur MA; Ankara Yildirim Beyazit University, Department of Internal Medicine, Division of Medical Oncology, Ankara, Türkiye.
  • Demirci U; Memorial Ankara Hospital, Department of Internal Medicine, Division of Medical Oncology, Ankara, Türkiye.
  • Goksu SS; Akdeniz Univesity, Department of Internal Medicine, Division of Medical Oncology, Antalya, Türkiye.
  • Er O; Acibadem University, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Türkiye.
  • Bisgin A; Cukurova University, Department of Medical Genetics, Adana, Türkiye.
  • Ozturk Saglam OF; Pfizer Pharmaceuticals, Medical Oncology Department, Istanbul, Türkiye.
  • Aver B; Pfizer Pharmaceuticals, Medical Oncology Department, Istanbul, Türkiye.
  • Kilickap S; Istinye University, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Türkiye.
Future Oncol ; 20(15): 1031-1045, 2024 May.
Article en En | MEDLINE | ID: mdl-38014519
Recent studies show that testing for a specific gene change in people newly diagnosed with breast cancer can help reduce the impact the disease has on their life as they can be given special treatments. When tests are tailored to each person, they can get better results. However, in many countries, including Türkiye, not many people know about or can get these tests. This is because of concerns about being judged, rules in the country, the cost, confusion about the tests and limited access. Not having these tests can make healthcare more expensive in the long run. This article suggests ways for Türkiye's leaders and health workers to make these tests a regular part of cancer care and planning.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 País/Región como asunto: Asia Idioma: En Revista: Future Oncol Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 País/Región como asunto: Asia Idioma: En Revista: Future Oncol Año: 2024 Tipo del documento: Article